Dabur India Ltd
NSE:DABUR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (48.7), the stock would be worth ₹565.1 (28% upside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 38 | ₹440.35 |
0%
|
| 3-Year Average | 48.7 | ₹565.1 |
+28%
|
| 5-Year Average | 50.2 | ₹582.36 |
+32%
|
| Industry Average | 34.3 | ₹398.03 |
-10%
|
| Country Average | 23.3 | ₹269.96 |
-39%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
₹879.8B
|
/ |
Jan 2026
₹19.5B
|
= |
|
|
₹879.8B
|
/ |
Mar 2026
₹21.2B
|
= |
|
|
₹879.8B
|
/ |
Mar 2027
₹27.8B
|
= |
|
|
₹879.8B
|
/ |
Mar 2028
₹25.5B
|
= |
|
|
₹879.8B
|
/ |
Mar 2029
₹33.6B
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
|
Dabur India Ltd
NSE:DABUR
|
785.5B INR | 38 | 42.4 | |
| FR |
|
L'Oreal SA
PAR:OR
|
187.8B EUR | 21 | 30.6 | |
| UK |
|
Unilever PLC
LSE:ULVR
|
93.1B GBP | 12.9 | 11.3 | |
| IN |
|
Hindustan Unilever Ltd
NSE:HINDUNILVR
|
5.3T INR | 38.4 | 36.2 | |
| UK |
|
HALEON PLC
LSE:HLN
|
31.7B GBP | 15.2 | 19 | |
| US |
|
Estee Lauder Companies Inc
NYSE:EL
|
28.2B USD | 23 | -158.2 | |
| DE |
|
Beiersdorf AG
XETRA:BEI
|
16.9B EUR | 10.6 | 18 | |
| JP |
|
Kao Corp
TSE:4452
|
2.7T JPY | 15.2 | 22.8 | |
| IN |
|
Godrej Consumer Products Ltd
NSE:GODREJCP
|
1.1T INR | 41 | 62.2 | |
| CA |
|
Relevium Technologies Inc
XTSX:RLV
|
12.2B CAD | -6 360.4 | -4 624.4 | |
| JP |
|
Shiseido Co Ltd
TSE:4911
|
1.3T JPY | 33.3 | -31.7 |
Market Distribution
| Min | 0.4 |
| 30th Percentile | 15.7 |
| Median | 23.3 |
| 70th Percentile | 34.7 |
| Max | 48 145.1 |
Other Multiples
Dabur India Ltd
Glance View
Dabur India Ltd., rooted deeply in the rich tapestry of ancient Ayurvedic traditions, has organically evolved into one of India's leading FMCG companies. Established in the late 19th century by Dr. S.K. Burman, Dabur began its journey with a mission to provide effective and affordable healthcare solutions. Over the years, the company has skillfully blended age-old wisdom with modern scientific research to craft a diverse product portfolio ranging from personal care products, health supplements, and digestives to over-the-counter medications and foods. This unique approach harnessing the virtues of natural ingredients has not only won consumer trust but also solidified Dabur's standing as a pioneer in herbal and natural products. The engine that drives Dabur’s financial performance is its expansive product range, complemented by an extensive distribution network that spans both urban and rural India. By strategically tapping into various sectors such as health care, personal care, and foods, Dabur has effectively spread its revenue streams, reducing dependency on any single category. With flagship brands like Dabur Chyawanprash, Dabur Honey, Vatika, and Real, the company enjoys strong brand equity. It continuously invests in marketing and innovation to expand its reach and engage a broader audience. Additionally, its export operations cater to the global demand for natural and holistic products, further bolstering revenue. Dabur's ability to adapt and innovate while staying true to its natural-centric philosophy ensures its robust presence in both domestic and international markets.